These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 28369830)

  • 1. Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.
    Oura T; Cosimi AB; Kawai T
    Clin Exp Immunol; 2017 Aug; 189(2):190-196. PubMed ID: 28369830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitating cells as a venue to establish mixed chimerism and tolerance.
    Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
    Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
    Leventhal JR; Ildstad ST
    Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.
    Sasaki H; Oura T; Spitzer TR; Chen YB; Madsen JC; Allan J; Sachs DH; Cosimi AB; Kawai T
    Hum Immunol; 2018 May; 79(5):258-265. PubMed ID: 29175110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance induction: hematopoietic chimerism.
    Kawai T; Sachs DH
    Curr Opin Organ Transplant; 2013 Aug; 18(4):402-7. PubMed ID: 23838644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transplant tolerance through mixed chimerism].
    Zuber J
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S127-S130. PubMed ID: 28577733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hurdles to the induction of tolerogenic mixed chimerism.
    Pilat N; Klaus C; Schwaiger E; Wekerle T
    Transplantation; 2009 May; 87(9 Suppl):S79-84. PubMed ID: 19424016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance.
    Granados JM; Benichou G; Kawai T
    Curr Opin Organ Transplant; 2015 Feb; 20(1):49-56. PubMed ID: 25563992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.
    Podestà MA; Sykes M
    Front Immunol; 2021; 12():791725. PubMed ID: 35069574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials for renal allograft tolerance induction through combined hematopoietic stem cell transplantation: A narrative review.
    Hotta K; Hirose T; Kawai T
    Int J Urol; 2022 Dec; 29(12):1397-1404. PubMed ID: 36101964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
    Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
    Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism.
    Kawai T; Cosimi AB; Sachs DH
    Curr Opin Organ Transplant; 2011 Aug; 16(4):366-71. PubMed ID: 21666482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
    Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of chimerism formation and tolerance induction from Fas ligand mutant bone marrow donors after nonmyeloablative conditioning.
    Nusair S; Gincberg G; Almogi-Hazan O; Breuer R; Or R; Wallach-Dayan SB
    Transpl Immunol; 2012 Dec; 27(4):184-8. PubMed ID: 22801052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.